Cardiovascular disease is a national priority and well-recognised as a driver of health inequalities. This session will consider the current position with regards to CVD prevention and opportunities for pharmacy across all sectors to deliver at pace and scale.

1. To describe the role of CV risk factors in driving CV mortality, morbidity and associated health inequalities
2. To understand the current level of performance relating to detection and management of the three high risk conditions, AF, blood pressure and cholesterol
3. To highlight the current priorities of the national CVD Prevention programme
4. To demonstrate the opportunities for pharmacy to deliver better outcomes in people with or at risk of CVD